MedPAC recommended a 7% Medicare home health cut for CY2027. The proposed rule lands in weeks.

On March 13, the Medicare Payment Advisory Commission released its annual Report to Congress with a clear signal for CY2027: cut the Medicare home health base payment rate by 7%. MedPAC's recommendation isn't binding — Congress and CMS can and do diverge from it. But the March report sets the policy runway for the CY2027 proposed rule, which CMS typically publishes in June or July. That timeline is now weeks away, not months.

What MedPAC found

The commission's payment-adequacy analysis for home health came in strong across every indicator. The 2024 Medicare fee-for-service margin for HHAs was 21.2%, up from 19.8% in 2023. MedPAC projects the 2026 FFS margin at 19% — a slight decline from the 2024 peak, but still well above the range the commission considers appropriate for a sector where access is adequate and quality is stable.

MedPAC Chair Michael Chernew's summary was direct: "The signal here is the margins are very high and we think the margins should be lower." MedPAC found no access crisis, no quality degradation, and no capital constraint that argued against a material cut. That read on all three indicators is what drove a 7% recommendation rather than the incremental adjustments seen in recent years.

At 7%, the aggregate impact would be $750 million to $2 billion in reduced federal spending in year one, and $10 billion to $25 billion over five years — depending on behavioral response (volume shifts, market exits, mix changes).

Why the industry is pushing back

Jennifer Sheets, CEO of the National Alliance for Care at Home, called the recommendation "dangerous and misguided, and would exacerbate a growing access crisis for care in the home." The industry's counter-argument centers on two points MedPAC's margin math doesn't capture.

First, the 21.2% margin is a survivor-population figure. Agencies that couldn't absorb four years of cumulative PDGM and behavioral-adjustment pressure have already closed. Their patients are the ones having the hardest time finding home health now. The population of agencies still operating is, by construction, the higher-margin cohort.

Second, the workforce math is brutal. The same market conditions that produce 21% FFS margins leave agencies paying recruiting premiums for RNs and competing with retail for direct-care workers at sub-$20/hour. Aggregate margin doesn't mean every individual agency has slack to absorb a 7% revenue reduction without workforce or access consequences.

How this compares to CY2026

The CY2026 final rule finalized a 1.3% net cut (~$220 million) after CMS proposed 6.4% and the industry campaigned heavily for a smaller number. That was an incremental result. A 7% CY2027 cut, if finalized, is structural: it would offset multiple years of gains built on case-mix management, efficiency improvement, and cost discipline. A 100-patient agency generating $3.5 million in Medicare HH revenue would absorb roughly $245,000 in rate-driven revenue reduction — before any volume or mix change.

What an agency should do now

1. Run the 7% scenario against your current case mix. You need to know your per-episode margin under current rates and under a 7% cut, by HHRG group. The proposed rule will narrow the window for operational response.
2. Review your payer mix exposure. The 7% cut affects Medicare FFS only. Agencies with substantial MA, Medicaid, or private-pay books have a different exposure profile than pure FFS agencies.
3. Identify recoverable revenue before the rule drops. LUPA-risk visits, documentation-driven denials, billing holds, and AVS authorization delays all represent margin that's already earned but not yet collected. In a 7% headwind, those fixes are not optional.
4. Engage in the comment process. The Alliance and state associations will coordinate comment campaigns once the proposed rule publishes. Individual agency comments that document specific access impact in your market carry weight — CMS reads them. The time to prepare your data is now, not after publication.

What we built for this

Carelytic's financial dashboard lets you model per-episode revenue under different PDGM rate scenarios — run the 7% cut against your current case mix today to see your 2027 exposure before the proposed rule publishes. The LUPA Risk Dashboard surfaces at-risk 30-day periods sorted by margin-to-threshold distance so schedulers know which periods to protect this week. And the billing-hold worklist keeps AR moving so rate pressure doesn't compound into extended collection cycles on top of a reduced rate.

The broader point: a 7% MedPAC recommendation is a 2026 planning problem, not a 2027 problem. The proposed rule will give agencies 60 days to comment — not 60 days to build their scenario models.